Serum concentrations of PIIINP aminopeptide in dogs with liver fibrosis

• Autorzy: Glinska-Suchocka K. , Orlowska A. , Jankowski M. , Kubiak K. , Spuzak J.
• Języki publikacji: EN

Abstrakty

EN

The aim of the study was to evaluate the serum concentration of the type III procollagen aminopeptide in dogs, and to assess its utility in the diagnosis of liver fibrosis. The study was carried out on 20 dogs of different breeds and of both genders, between 7 and 15 years old. Based on the results of the histopathological examination and the evaluation of the degree of liver fibrosis, the dogs were divided into five groups. The mean serum PIIINP concentration in the group of dogs with stage 1 and 2 liver fibrosis (groups 2 and 3) was five-fold higher than in healthy dogs (group 1). In turn, the mean PIIINP concentration in the group of dogs with stage 3 (group 4) and stage 4 (group 5) fibrosis was 10-fold higher than that of the control group (group 1). Based on the results, we found that the serum PIIINP concentration correlated with the degree of liver fibrosis, assessed based on a histopathological examination. Therefore, PIIINP serum concentration tests may be a promising non-invasive diagnostic technique that could be used in veterinary hepatology to assess the degree of liver fibrosis.

• Wydawca: -
• Czasopismo: Polish Journal of Veterinary Sciences
• Rocznik: 2016
• Tom: 19
• Numer: 2
• Opis fizyczny: p.365-369,fig.,ref.

Twórcy

autor

Glinska-Suchocka K.

• Department of Internal Diseases with Clinic of Horses, Dogs and Cats, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, pl. Grunwaldzki 47, 50-366 Wroclaw, Poland

autor

Orlowska A.

• Department of Biochemistry, Pharmacology and Toxicology, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Norwida 31, 50-375 Wroclaw, Poland

autor

Jankowski M.

• Department of Internal Diseases with Clinic of Horses, Dogs and Cats, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, pl. Grunwaldzki 47, 50-366 Wroclaw, Poland

autor

Kubiak K.

• Department of Internal Diseases with Clinic of Horses, Dogs and Cats, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, pl. Grunwaldzki 47, 50-366 Wroclaw, Poland

autor

Spuzak J.

• Department of Internal Diseases with Clinic of Horses, Dogs and Cats, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, pl. Grunwaldzki 47, 50-366 Wroclaw, Poland

Bibliografia

• Bentsen KD, Horn T, Risteli J, Risteli L, Engstrom-Laurent A, Hørslev-Petersen K, Lorenzen I (1987) Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronan. Liver 7: 339-346.
• Goodman ZD (2007) Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol 47: 598-607.
• Guarino M, Tosoni A, Nebuloni M (2009) Direct contribution of epithelium to organ fibrosis: epithelial-mesenchylam transition. Hum Pathol 40: 1365-1376.
• Gutkowski K, Kamińska E, Pluta A (2007) The role of non-invasive diagnostics in assessment of hepatic fibrosis progression. Gastroenterol Pol 14: 363-367.
• Harju T, Kinnula VL, Paakko, P, Salmenkivi K, Risteli J, Kaarteenaho R (2010) Variability in the precursor proteins of collagen I and III in different stages of COPD. Respir Res 11: 165.
• Heikkilä HP, Krafft E, Jespers P, McEntee K, Rajamäki MM, Clercx C (2013) Procollagen type III amino terminal propeptide concentrations in dogs with idiopathic pulmonary fibrosis compared with chronic bronchitis and eosinophilic bronchopneumopathy Vet J 196: 52-56.
• Hezzell MJ, Falk T, Olsen LH, Boswood A, Elliott J (2014) Associations between N-terminal procollagen type III, fibrosis and echocardiographic indices in dogs that died due to myxomatous mitral valve disease J Vet Cardiol 16: 257-264,
• Izawa H, Murohara T, Nagata K, Isobe S, Asano H, Amano T, Ichihara S, Kato T, Ohshima S, Murase Y, Iino S, Obata K, Noda A, Okumura K, Yokota M (2005) Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study. Circulation 112: 2940-2945.
• Klappacher G, Franzen P, Haab D, Mehrabi M, Binder M, Plesch K, Pacher R, Grimm M, Pribill I, Eichler HG, Glogar HD (1995) Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Am J Cardiol 158: 1432-1441.
• Kruś S, Skrzypek-Fakhoury E (2007) Patomorfologia kliniczna. 3th ed., PZWL, Warszawa.
• Lammi L, Kinnula V, Lähde S, Risteli J, Pääkkö P, Lakari E, Ryhänen L (1997) Propeptide levels of type III and type I procollagen in the serum and bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. Eur Respir J 10: 2725-2730.
• Meduri GU, Tolley EA, Chinn A, Stenzt F, Postlethwaite A (1998). Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am J Respir Crit Care Med 158: 1432-1441.
• Norris, AJ, Naydan DK, Wilson DW (2005) Interstitial lung disease in West Highland White Terriers. Vet Pathol 42: 35-41.
• Nouchi T, Worner TM, Sato S, Lieber CS. (1987) Serum procollagen type III N-terminal peptides and laminin P1 peptide in alcoholic liver disease. Alcohol Clin Exp Res 11: 287-291.
• Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Aubé C, Gallois Y, Rifflet H, Maȉga MY, Penneau-Fontbonne D, Calms P (1997) Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 113: 1609-1616.
• Parkes J, Roderick P, Harris S, Day C, Mutimer D, Collier J, Lombard M, Alexander G, Ramage J, Dusheiko G, Wheatley M, Gough C, Burt A, Rosenberg W. (2010) Enhanced Liver Fibrosis Test Can Predict Clinical Outcome in Patients with Chronic Liver Disease’ Gut 59: 1245-1251
• Pinzani M (2010) The ELF panel: a new crystal ball in hepatology? Gut 59: 1165-1167.
• Pinzani M, Macias-Barragan J (2010) Update on the pathophysiology of liver fibrosis. Expert Rev Gastroenterol Hepatol 4: 459-472.
• Prockop DJ, Kivirikko KI, Tuderman L, Guzman NA (1979) The biosynthesis of collagen and its disorders, N Engl J Med 301: 13-23.
• Rosenberg WM, Voelker M, Thiel R, Becka M, Burt A, Schuppan D, Hubscher S, Roskams T, Pinzani M, Arthur MJ (2004) Serum Markers Detect the Presence of Liver Fibrosis: A Cohort Study Gastroenterology 127: 1704-1713.
• Stickel F, Urbaschek R, Schuppan D, Poeschl G, Oesterling C, Conradt C, McCuskey RS, Simanowski UA, Seitz HK (2001) Serum collagen type VI and XIV and hyaluronic acid as early indicators for altered connective tissue turnover in alcoholic liver disease. Dig Dis Sci 46: 2025-2032.
• Torres-Salinas M, Parés A, Caballerıa J, Jiménez W, Heredia D, Bruguera M, Rodés J (1986) Serum procollagen Type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis. Gastroenterology 90: 1241-1246.
• Tran A, Benzaken S, Saint-Paul MC, Guzman-Granier E, Hastier P, Pradier C, Barjoan EM, Demuth N, Longo F, Rampal P (2000) Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease. Eur J Gastroenterol Hepatol 12: 989-993.
• Trinchet JC, Hartmann DJ, Pateron D, Munz-Gotheil C, Callard P, Ville G, Beaugrand M (1992) Serum Type I collagen and N-terminal peptide of Type III procollagen in patients with alcoholic liver disease: relationship to liver histology. Alcohol Clin Exp Res 16: 342-346.

Identyfikatory

DOI

10.1515/pjvs-2016-0045